Home » Topics » BioWorld Science

BioWorld Science
RSS

Ibex issued U.S. patent for recombinant heparinase

Nov. 19, 1997

rhIL-11 effective in rats with adjuvant arthritis

Nov. 19, 1997

Basiliximab reduces renal allograft rejection in phase III trial

Nov. 19, 1997

Scripps prepares MCBI analogues of antitumor antibiotics

Nov. 19, 1997

rhIL-10 evaluated for safety and efficacy in RA patients

Nov. 19, 1997

Complement activation inhibitors prepared at U of Pennsylvania

Nov. 19, 1997

Cell Genesys issued U.S. patent for gene therapy

Nov. 19, 1997

Rogaine Extra Strength approved by FDA as OTC

Nov. 19, 1997

New cardiotonic agent reported by Japanese academics

Nov. 19, 1997

MiKasome enters phase II for UTI

Nov. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...